Panacea arm defaults; lenders may extend repayment date

Panacea Biotec Pharma, a 100% subsidiary of Sputnik V Covid jab manufacturer Panacea Biotec, defaulted on payment of ₹114.67 crore including an interest component due on September 30.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3kK8knM
via IFTTT